VCWA
MRNA icon

Vanguard Capital Wealth Advisors’s Moderna MRNA Stock Holding History

Vanguard Capital Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,485
Closed -$428K – 143
2022
Q1 		$428K Buy
2,485
+1,625
+189% +$274K 0.31% 82
2021
Q4 		$218K Buy
860
+25
+3% +$7.31K 0.16% 124
2021
Q3 		$322 Buy
+835
New +$308K 0.22% 93

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Capital Wealth Advisors's MRNA Position: Q2 2022 in Review

Vanguard Capital Wealth Advisors sold out of Moderna (MRNA) in Q2 2022, closing a stake of 2,485 shares — an estimated $428K sold.

Vanguard Capital Wealth Advisors first reported a position in MRNA in Q3 2021 and held it in 3 quarters. The position peaked at $428K in Q1 2022. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Vanguard Capital Wealth Advisors reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Vanguard Capital Wealth Advisors sold 2,485 Moderna shares in Q2 2022, an estimated $428K.
  • Vanguard Capital Wealth Advisors first reported a position in Moderna in Q3 2021 and held it in 3 quarters.
  • Vanguard Capital Wealth Advisors's Moderna position peaked at $428K in Q1 2022.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Vanguard Capital Wealth Advisors's 13F filing for Q2 2022, filed 4 Aug 2022.